"Midwest Immunology is specialized in the evaluation and treatment of infants, children, and adults with diseases related to the immune system, including primary immune deficiencies and autoimmunity. We focus on meeting both the physical and emotional needs of those living with difficult chronic medical conditions. Midwest Immunology does more than treat a disease. Through comprehensive programs and services, we support our patients and those who care for them. Our staff is available and ready to answer any questions or concerns you may have, please call or stop by for more information."

During the past decade, Midwest Immunology Clinic conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Midwest Immunology Clinic" #1 sponsor was "Kedrion S.p.A." with 2 trials, followed by "Shire" with 2 trials sponsored, "Baxalta now part of Shire" with 1 trials sponsored, "CSL Behring" with 1 trials sponsored and "Green Cross Corporation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Midwest Immunology Clinic" #1 collaborator was "Atlantic Research Group" with 1 trials as a collaborator, "Dyax Corp." with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "Regulatory Clinical Research Institute (RCRI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Midwest Immunology Clinic" are "Hereditary Angioedema (HAE)" (2 trials), "Primary Immunodeficiency" (2 trials), "Agammaglobulinemia" (1 trials), "Antibody Deficiency" (1 trials) and "Difficult-to-access Veins for Intravenous Cannulation" (1 trials). Many other conditions were trialed in "Midwest Immunology Clinic" in a lesser frequency.

Most popular intervention types in "Midwest Immunology Clinic" are "Biological" (6 trials), "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Kedrion IVIG 10%" (2 trials), "DX-2930" (1 trials), "DX-2930 - 150mg/4wk" (1 trials), "DX-2930 - 300mg/2wk" (1 trials) and "DX-2930 - 300mg/4wk" (1 trials). Other intervention names were less common.

The vast majority of trials in "Midwest Immunology Clinic" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Midwest Immunology Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Midwest Immunology Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Midwest Immunology Clinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".